“The simplicity of Eurofins DiscoverX assay platform, coupled with a broad menu, makes it attractive for our clients to use them in potency, immunogenicity, and stability testing programs. We at VelaLabs, headquartered in Vienna, are a GMP-certified and GCLP-compliant contract laboratory that offers in-depth analytical characterization services for pharmaceuticals including biosimilars, hormones, monoclonal antibodies and peptides. It is apparent to us that the ready-to-use, qualified Bioassays from DiscoverX has resulted in a faster implementation timeline for QC testing programs and could potentially expedite product commercialization and market release of drug candidates for our clients. We are looking to receive your requests.”
Markus Roucka, CBDO / Managing Director at Vela Laboratories (Vienna, Austria)
“We find Eurofins DiscoverX PathHunter® cell-based assays are target-specific and MOA-reflective, and are an integral part of the GMP/GLP-compliant expertise that we provide for our customers. Catalent provides support for an extensive range of large and small molecule analytical products. As a certified provider of Eurofins DiscoverX PathHunter assay services, we are able to leverage our strong track-record to expeditiously implement multiple customer-sponsored validation programs using the PathHunter assay platform to perform highly reproducible potency lot-release assays under GLP/GMP conditions. In our experience, their thaw-and-use Bioassays can reduce assay development timelines by several months. And since their assays are pre-qualified with marketed biologic drugs or reference standards, they also help in risk mitigation when implementing in stability and potency testing programs.”
Ramsey Connor, Biologics Supervisor and RSO at Catalent Pharma Solutions (Morrisville, NC, USA)
Andy Wallace, Ph.D. (Principal Scientist) at Catalent Pharma Solutions (Morrisville, NC, USA)
